Europe’s biggest private biotech company raises $270 mln
03 Jan Europe’s biggest private biotech company raises $270 mln
Posted at 07:30h
in
News
by KMFSLLP
LONDON, Jan 4 (Reuters) – Europe’s largest privately held
biotech company, Germany-based BioNTech, has raised $270 million
to support its work in developing personalised immunotherapies
for cancer, ahead of an expected eventual stock market
flotation.
Sorry, the comment form is closed at this time.